"An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving (Melt) Formulation of Desmopressin for the Treatment of Nocturia in Adults"

PHASE3CompletedINTERVENTIONAL
Enrollment

554

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Nocturia
Interventions
DRUG

Desmopressin Melt

An orally disintegrating tablet of desmopressin administered under the tongue (sublingually), without water.

Trial Locations (73)

10016

University Urology Associates, New York

10512

Investigational site - Adult & Pediatric Urology, Carmel

11530

AccuMed Research Associates, Garden City

12601

Hudson Valley Urology, PC, Poughkeepsie

19004

Urologic Consultants of SE PA, Bala-Cynwyd

19114

Philadelphia Clinical Research, LLC, Philadelphia

19611

Advanced Clinical Concepts, West Readings

23235

Virginia Urology, Richmond

23454

Urology of Virginia PC, Virginia Beach

27103

Piedmont Medical Research Associates, Winston-Salem

27408

PharmQuest, Greensboro

28401

New Hanover Medical Research, Wilmington

29464

Palmetto Medical Research, Mt. Pleasant

29572

Carolina Urologic Research Center, Myrtle Beach

29651

Radiant Research, Greer, Greer

30338

Investigational site, Dunwoody

31904

Southeastern Medical Research Institute, Columbus

33180

South Florida Medical Research, Aventura

33324

Sunrise Medical Research, Plantation

33407

Radiant Research, West Palm Beach

33607

Tampa Bay Urology, Tampa

33759

Women's Health Research Group, LLC, Clearwater

33781

Radiant Research - St. Petersburg, Pinellas Park

34996

Radiant Research, Stuart

37660

Holston Medical Group, Kingsport

44260

Radiant Research - Akron, Mogadore

45249

Radiant Research Inc., Cincinnati

55435

Radiant Research, Minneapolis, Edina

60654

Radiant Research, Inc, Chicago

61602

Accelovance, Peoria

63141

Radiant Research, Inc., St Louis

66202

Radiant Research, Kansas City, Overland Park

68510

Women's Clinic of Lincoln, P.C., Lincoln

70006

Benchmark Research, Metairie

71106

Regional Urology, LLC, Shreveport

72204

Arkansas Primary Care Clinic, PA, Little Rock

77004

Investigational site - NationsMed Clinical Research, Houston

77024

Accelovance, Houston

77338

Regional Medical Center and Diagnostic, Humble

78229

Innovative Clinical Trials, San Antonio

Radiant Research San Antonio, San Antonio

78258

IMED Research, P.A., San Antonio

78414

Advanced Research Associates, Corpus Christi

80210

Urology Associates PC, Denver

80218

Downtown Women's Health Care, Denver

80220

Genitourinary Surgical Consultants, Denver

85251

Radiant Research, Scottsdale

87109

Urology Group of New Mexico, PC, Albuquerque

90211

Impact Clinical Trials, Beverly Hills

90505

Western Clinical Research, Torrance

91356

West Coast Clinical Research, Tarzana

92103

San Diego Uro-Reseach, San Diego

92660

California Professional Research, Newport Beach

92801

Advanced Urology Medical Center, Anaheim

95405

Radiant Research, Santa Rosa

98105

Women's Clinical Research Center, Seattle

98166

Seattle Urology Research Center, Seattle

06762

Connecticut Clinical Research Center, LLC, Middlebury

01103

FutureCare Studies, Inc., Springfield

Unknown

Sheldon J Freedman Ltd, Las Vegas

NationsMed, Stafford

07202

Central Jersey Medical Research Center, Elizabeth

08648

Lawrenceville Urology, P.A. DBA, Lawrenceville

12206-1092

Upstate Urology, New York

V1Y-2H4

Southern Interior Medical Research Inc., Kelowna

V8T 5G1

Can-Med Clinical Research Inc., Victoria

V8V 3N1

Investigational site - Clinical Research, Victoria

E3B 5B8

Investigational site - Professional Corporation, Fredericton

L4M 7G1

The Male/Female Health and Research, Barrie

N3R 4N3

Brantford Urology Research, Brantford

N1H 5J1

Guelph Urology Associates, Guelph

P1B 7K8

Investigational site, North Bay

L6H 3P1

The Fe/Male Health Centres, Oakville

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT00615836 - "An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving (Melt) Formulation of Desmopressin for the Treatment of Nocturia in Adults" | Biotech Hunter | Biotech Hunter